Table 1.
Comparative analysis between the three subgroups regarding the final pathological findings.
| Final Pathology Parameters | Group I: n = 983 (%) |
Group II: n = 2223 (%) |
Group III: n = 688 (%) |
|---|---|---|---|
| Presence of any PCa, no (%) | 212 (21.5) | 825 (37.7) | 134 (19.5) |
| Presence of csPCa, no (%) | 111 (11.3) | 362 (16.3) | 71 (10.3) |
| Presence of ECE (pT3), no (%) | 45 (4.5) | 85 (3.8) | 38 (5.5) |
| Positive frozen section analysis, no (%) | 51 (5.2) | 102 (4.5) | 27 (4) |
| Presence of PSMs, no (%) | 18 (1.8) | 61 (2.7) | 11 (1.5) |
Abbreviations: PCa—prostate cancer, csPCa—clinically significant prostate cancer, ECE—extracapsular extension of cancer, PSM—positive surgical margins.